Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy in Patients With Ragweed Pollinosis: a Phase III Randomized and Controlled Clinical Study. [Confronto dell`efficacia e della sicurezza di diversi schemi di somministrazione dell`immunoterapia sub-linguale in pazienti con pollinosi da ambrosia: studio clinico randomizzato controllato di fase III].

Trial Profile

Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy in Patients With Ragweed Pollinosis: a Phase III Randomized and Controlled Clinical Study. [Confronto dell`efficacia e della sicurezza di diversi schemi di somministrazione dell`immunoterapia sub-linguale in pazienti con pollinosi da ambrosia: studio clinico randomizzato controllato di fase III].

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Ragweed allergy immunotherapy; Ragweed allergy immunotherapy
  • Indications Ragweed pollen hypersensitivity
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Oct 2012 New source identified and integrated (EudraCT2011-001682-41: European Clinical Trials Database).
    • 05 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top